Policy and Payment Factors Influencing Adoption of Low-Barrier Buprenorphine Treatment
-
By
-
Margaret Lowenstein
-
M. Holliday Davis
-
Selena Suhail-Sindhu
-
Gary McMurtrie
-
David Grande
-
Julia Hinckley
-
Shoshana V. Aronowitz
-
June 16, 2026
-
Clinical Scorecard: Factors Related to Policy and Payment Affecting the Implementation of Accessible Buprenorphine Treatment
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Individuals with Opioid Use Disorder (OUD) in Philadelphia, Pennsylvania. |
| Care Setting | |
Key Highlights
- Qualitative study conducted with clinicians and staff in Philadelphia to explore barriers and solutions.
Guideline-Based Recommendations
Diagnosis
- Utilize standardized diagnostic criteria for Opioid Use Disorder (OUD).
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Low-barrier practices include flexible treatment models and tolerance of ongoing substance use, supported by evidence.
Clinical Best Practices
- Implement low-barrier strategies to facilitate rapid access to treatment.
- Utilize evidence-based practices across various treatment settings.
- Provide ongoing training for practitioners to support low-barrier practices.
Related Resources & Content
